Resources Contact Us Home
Lachance; Nicholas
Pierrefonds, CA
No. of patents:

Patent Number Title Of Patent Date Issued
7429666 Pyridine analogs as C5a antagonists September 30, 2008
The present invention provides novel compounds of Formula I which are antagonists of the C5a receptor. Compounds of the present invention are useful for the treatment of various C5a-mediated diseases and disorders; accordingly the present invention provides a method for the treatment of
6211197 Prostaglandin receptor ligands April 3, 2001
Compounds and methods for treating prostaglandin mediated diseases, and certain pharmaceutical compositions thereof are disclosed. The compounds are represented by formula II:The compounds of the invention are structurally different from NSAIDs and opiates, and are antagonists of the pai

  Recently Added Patents
Fuel cell and a method of manufacturing a fuel cell
Synthesis of 8-amino boron dipyrromethenes having blue fluorescence
Primed stem cells and uses thereof to treat inflammatory conditions in joints
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
Developing cartridge
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
Motor drive component verification system and method
  Randomly Featured Patents
Curvature conformable gripping dies
System and method for inductive power provision over an extended surface
Current limiting circuit breaker with high speed magnetic trip device
Zipper pull
Projector light source utilizing a solid state green light source
Fluid flow control in curved capillary channels
Process for sidewall amplification of resist structures and for the production of structures having reduced structure size
Telephone enclosure assembly and directory holder apparatus
Golf club driver head
Native wi-fi architecture for 802.11 networks